IHS Chemical Week

Regions :: North America :: U.S.

Bayer Sues Teva for Patent Infringement

8:29 AM MDT | July 6, 2009 | Natasha Alperowicz

Bayer Schering Pharma AG,  Bayer HealthCare Pharmaceuticals Inc., and Schering Corporation have jointly filed a patent infringement lawsuit in the U.S. Federal Court in the District of Delaware against Teva Pharmaceuticals USA and Teva Pharmaceutical Industries Ltd. The lawsuit concerns Teva's application to the FDA for approval to market a generic form of Levitra, Bayer Schering Pharma's therapy for the treatment of erectile dysfunction, prior to patent expiration. Bayer says the patent at issue is Bayer Schering Pharma's U.S. Patent No. 6,362,178...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa